Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Conducting Sampling at Intervals – V 2.0

Posted on By

SOP for Conducting Sampling at Intervals – V 2.0

Procedure for Conducting Sampling at Intervals

Department Quality Control (QC)/Production
SOP No. SOP/Ointment/073
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish a systematic method for conducting sampling at defined intervals during ointment manufacturing to ensure batch consistency, quality, and compliance with regulatory standards.

2. Scope

This SOP applies to Quality Control (QC) and Production personnel involved in in-process sampling of ointments at various stages of manufacturing, including raw material processing, mixing, filling, and packaging.

3. Responsibilities

  • Quality Control Analyst: Conducts sampling, performs tests, and records results.
  • Production Operator: Provides samples at designated time intervals.
  • Production Supervisor: Ensures adherence to sampling schedules and protocols.
  • Quality Assurance (QA) Personnel: Reviews and approves sampling records.

4. Accountability

The QC and QA Managers are accountable for ensuring that interval sampling is performed correctly and documented according to GMP and regulatory requirements.

See also  Ointments: SOP for Labeling Ointment Containers - V 2.0

5. Procedure

5.1 Equipment and Materials

  • Sterile sampling containers
  • Sterile spatulas or pipettes
  • Labeling materials (sample tags, barcode labels)
  • Temperature and humidity monitoring devices (if required)
  • Sampling logbook or electronic system

5.2 Sampling Frequency

  • Raw Materials: Sample each batch upon receipt and before use.
  • Mixing Stage: Sample at defined intervals (e.g., every 30 minutes or as per batch record).
  • Filling Stage: Collect
samples every predetermined number of filled containers.
  • Final Product: Take final samples before batch release for QC testing.
  • 5.3 Sampling Procedure

    5.3.1 Raw Material Sampling

    • Use a sterile spatula to collect a representative sample.
    • Transfer sample into a clean, labeled container.
    • Seal and document the sample in the Raw Material Sampling Log.

    5.3.2 In-Process Sampling

    • Collect the sample at pre-defined intervals during manufacturing.
    • Ensure the sample is representative of the batch.
    • Record observations such as texture, color, and viscosity.
    • Store samples as per storage conditions defined in the batch record.

    5.3.3 Finished Product Sampling

    • Collect samples from different locations of the batch (beginning, middle, and end).
    • Ensure that proper identification and documentation are maintained.
    • Send samples for microbiological, chemical, and physical testing.

    5.4 Acceptance Criteria

    • Samples must be collected as per defined intervals.
    • No contamination or cross-contamination should be observed.
    • All samples must be labeled and stored correctly.

    5.5 Documentation

    • Record all sample details in the Sampling Log.
    • Ensure traceability by maintaining batch-wise sample records.
    • QA personnel must review and approve all documentation.

    6. Abbreviations

    • GMP – Good Manufacturing Practices
    • QA – Quality Assurance
    • QC – Quality Control
    • BMR – Batch Manufacturing Record

    7. Documents

    • Sampling Log (Annexure-1)
    • Batch Sampling Record (Annexure-2)

    8. References

    • WHO GMP Guidelines for Pharmaceutical Manufacturing
    • USP <1116> – Microbiological Evaluation of Cleanrooms and Other Controlled Environments
    • ICH Q7 – Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

    9. SOP Version

    Version 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Sampling Log

    Date Batch Number Process Stage Sample ID Sampling Time Storage Condition Result Verified By
    01/02/2025 OINT-101 Mixing SMP-001 10:00 AM Room Temp Pass QA Officer
    01/02/2025 OINT-101 Filling SMP-002 12:00 PM Room Temp Pass QA Officer

    Annexure-2: Batch Sampling Record

    Date Batch Number Sampling Stage Time Interval Acceptance Criteria Result Final Status Approved By
    01/02/2025 OINT-101 Mixing 30 min Homogeneous Pass Approved QA Head
    01/02/2025 OINT-101 Final Product End of batch Meets specs Pass Approved QA Head

    12. Revision History:

    Revision Date Revision No. Details of Revision Reason for Revision Approved By
    01/01/2024 1.0 Initial Version New SOP QA Head
    01/02/2025 2.0 Updated SOP Format Standardization of Document QA Head
    Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

    Post navigation

    Previous Post: Aerosol: SOP for Formulation Development of Aerosol Products – V 2.0
    Next Post: SOP for Assessment of Taste-Masking Formulations

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version